Bhutan vs Democratic Republic of Congo: Access to anti-retroviral drugs, female (%)
Bhutan
80.0%
in 2024
Democratic Republic of Congo
78.0%
in 2024
Bhutan rank
57th
Democratic Republic of Congo rank
60th
Access to anti-retroviral drugs, female (%) over time
- Bhutan
- Democratic Republic of Congo
How they compare
Bhutan currently reports 80.0% against 78.0% in Democratic Republic of Congo, a difference of 2.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Democratic Republic of Congo ahead.
Bhutan ranks 57th and Democratic Republic of Congo ranks 60th of 141 countries.
Bhutan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bhutan | Democratic Republic of Congo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.0% | 2.0% | 2.0% | Bhutan |
| 2010s | 46.2% | 25.7% | 20.5% | Bhutan |
| 2020s | 74.8% | 70.2% | 4.6% | Bhutan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bhutan or Democratic Republic of Congo?
- Bhutan, at 80.0% against 78.0% in Democratic Republic of Congo as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bhutan and Democratic Republic of Congo?
- 2.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Democratic Republic of Congo?
- 25 years are reported by both, from 2000 to 2024.
- How do Bhutan and Democratic Republic of Congo rank globally for access to anti-retroviral drugs, female?
- Bhutan ranks 57th and Democratic Republic of Congo ranks 60th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.